Mechanistic target of rapamycin (MTOR) signaling during ovulation in mice

Molecular Reproduction and Development

Volumn 81, Issue 7, 2014, Pages 655-665

  Siddappa, Dayananda ^a   Kalaiselvanraja, Anitha ^a   Bordignon, Vilceu ^a   Dupuis, Lisa ^a   Gasperin, Bernardo G ^a,b   Roux, Philippe P ^c   Duggavathi, Raj ^a  

^a MCGILL UNIVERSITY   (Canada)

^b FEDERAL UNIVERSITY OF PELOTAS   (Brazil)

^c INSTITUTE FOR RESEARCH IN IMMUNOLOGY AND CANCER   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

MITOGEN ACTIVATED PROTEIN KINASE; MTOR PROTEIN, MOUSE; RAPAMYCIN; TARGET OF RAPAMYCIN KINASE;

ANIMAL; C57BL MOUSE; DRUG EFFECTS; FEMALE; METABOLISM; MOUSE; OVARY; OVARY FOLLICLE; OVULATION; PHYSIOLOGY; SIGNAL TRANSDUCTION;

ANIMALS; FEMALE; MICE; MICE, INBRED C57BL; MITOGEN-ACTIVATED PROTEIN KINASES; OVARIAN FOLLICLE; OVARY; OVULATION; SIGNAL TRANSDUCTION; SIROLIMUS; TOR SERINE-THREONINE KINASES;

EID: 84904419306     PISSN: 1040452X     EISSN: 10982795     Source Type: Journal    
DOI: 10.1002/mrd.22333     Document Type: Article

References (33)

1. Alam H, Maizels ET, Park Y, Ghaey S, Feiger ZJ, Chandel NS, Hunzicker-Dunn M. 2004. Follicle-stimulating hormone activation of hypoxia-inducible factor-1 by the phosphatidylinositol 3-kinase/AKT/Ras homolog enriched in brain (Rheb)/mammalian target of rapamycin (mTOR) pathway is necessary for induction of select protein markers of follicular differentiation. J Biol Chem 279:19431-19440.
2. Arvisais EW, Romanelli A, Hou X, Davis JS. 2006. AKT-independent phosphorylation of TSC2 and activation of mTOR and ribosomal protein S6 kinase signaling by prostaglandin F2α. J Biol Chem 281:26904-26913.
3. Ashkenazi H, Cao X, Motola S, Popliker M, Conti M, Tsafriri A. 2005. Epidermal growth factor family members: Endogenous mediators of the ovulatory response. Endocrinology 146:77-84.
4. Ben-Ami I, Armon L, Freimann S, Strassburger D, Ron-El R, Amsterdam A. 2009. EGF-like growth factors as LH mediators in the human corpus luteum. Hum Reprod 24:176-184.
5. Caron E, Ghosh S, Matsuoka Y, Ashton-Beaucage D, Therrien M, Lemieux S, Perreault C, Roux PP, Kitano H. 2010. A comprehensive map of the mTOR signaling network. Mol Syst Biol 6:453.
6. Carracedo A, Ma L, Teruya-Feldstein J, Rojo F, Salmena L, Alimonti A, Egia A, Sasaki AT, Thomas G, Kozma SC, Papa A, Nardella C, Cantley LC, Baselga J, Pandolfi PP. 2008. Inhibition of mTORC1 leads to MAPK pathway activation through a PI3K-dependent feedback loop in human cancer. J Clin Invest 118:3065-3074.
7. Chen YJ, Hsiao PW, Lee MT, Mason JI, Ke FC, Hwang JJ. 2007. Interplay of PI3K and cAMP/PKA signaling, and rapamycin-hypersensitivity in TGFbeta1 enhancement of FSH-stimulated steroidogenesis in rat ovarian granulosa cells. J Endocrinol 192:405-419.
8. Choo AY, Yoon SO, Kim SG, Roux PP, Blenis J. 2008. Rapamycin differentially inhibits S6Ks and 4E-BP1 to mediate cell-type-specific repression of mRNA translation. Proc Natl Acad Sci USA 105:17414-17419.
9. Chresta CM, Davies BR, Hickson I, Harding T, Cosulich S, Critchlow SE, Vincent JP, Ellston R, Jones D, Sini P. 2010. AZD8055 is a potent, selective, and orally bioavailable ATP-competitive mammalian target of rapamycin kinase inhibitor with in vitro and in vivo antitumor activity. Cancer Res 70:288.
10. Conti M. 2010. Signaling networks in somatic cells and oocytes activated during ovulation. Issy les Moulineaux, France: Elsevier. pp 189-190.
11. Deroo BJ, Rodriguez KF, Couse JF, Hamilton KJ, Collins JB, Grissom SF, Korach KS. 2009. Estrogen receptor beta is required for optimal cAMP production in mouse granulosa cells. Mol Endocrinol 23:955-965.
12. Dowling RJ, Topisirovic I, Fonseca BD, Sonenberg N. 2010. Dissecting the role of mTOR: Lessons from mTOR inhibitors. Biochim Biophys Acta 1804:433-439.
13. Duggavathi R, Volle DH, Mataki C, Antal MC, Messaddeq N, Auwerx J, Murphy BD, Schoonjans K. 2008. Liver receptor homolog 1 is essential for ovulation. Genes Dev 22:1871-1876.
14. Dunlop EA, Tee AR. 2009. Mammalian target of rapamycin complex 1: Signalling inputs, substrates and feedback mechanisms. Cell Signal 21:827-835.
15. Fan HY, Liu Z, Cahill N, Richards JS. 2008a. Targeted disruption of Pten in ovarian granulosa cells enhances ovulation and extends the life span of luteal cells. Mol Endocrinol 22:2128-2140.
16. Fan HY, Shimada M, Liu Z, Cahill N, Noma N, Wu Y, Gossen J, Richards JS. 2008b. Selective expression of KrasG12D in granulosa cells of the mouse ovary causes defects in follicle development and ovulation. Development 135:2127-2137.
17. Fan HY, Liu Z, Shimada M, Sterneck E, Johnson PF, Hedrick SM, Richards JAS. 2009. MAPK3/1 (ERK1/2) in ovarian granulosa cells are essential for female fertility. Sci STKE 324:938.
18. Hall MN. 2008. mTOR-what does it do? Transplant Proc 40:S5-S8.
19. Hou X, Arvisais EW, Davis JS. 2010. Luteinizing hormone stimulates mammalian target of rapamycin signaling in bovine luteal cells via pathways independent of AKT and mitogen-activated protein kinase: Modulation of glycogen synthase kinase 3 and AMP-activated protein kinase. Endocrinology 151:2846-2857.
20. Howell JJ, Manning BD. 2011. mTOR couples cellular nutrient sensing to organismal metabolic homeostasis. Trends Endocrinol Metab 22:94-102.
21. Kayampilly PP, Menon KM. 2007. Follicle-stimulating hormone increases tuberin phosphorylation and mammalian target of rapamycin signaling through an extracellular signal-regulated kinase-dependent pathway in rat granulosa cells. Endocrinology 148:3950-3957.
22. Kim J, Bagchi IC, Bagchi MK. 2009. Signaling by hypoxia-inducible factors is critical for ovulation in mice. Endocrinology 150:3392-3400.
23. Ma XM, Blenis J. 2009. Molecular mechanisms of mTOR-mediated translational control. Nat Rev Mol Cell Biol 10:307-318.
24. Murphy BD. 2000. Models of luteinization. Biol Reprod 63:2-11.
25. Ortega HH, Rey F, Velazquez MM, Padmanabhan V. 2010. Developmental programming: Effect of prenatal steroid excess on intraovarian components of insulin signaling pathway and related proteins in sheep. Biol Reprod 82:1065-1075.
26. Park JY, Su YQ, Ariga M, Law E, Jin SL, Conti M. 2004. EGF-like growth factors as mediators of LH action in the ovulatory follicle. Science 303:682-684.
27. Richards JS, Russell DL, Ochsner S, Espey LL. 2002. OVULATION: New dimensions and new regulators of the inflammatory-like response. Ann Rev Physiol 64:69-92.
28. Robker RL, Richards JS. 1998. Hormone-induced proliferation and differentiation of granulosa cells: A coordinated balance of the cell cycle regulators cyclin D2 and p27Kip1. Mol Endocrinol 12:924-940.
29. Sang N, Stiehl DP, Bohensky J, Leshchinsky I, Srinivas V, Caro J. 2003. MAPK signaling up-regulates the activity of hypoxia-inducible factors by its effects on p300. J Biol Chem 278:14013-14019.
30. Sarbassov DD, Ali SM, Sengupta S, Sheen JH, Hsu PP, Bagley AF, Markhard AL, Sabatini DM. 2006. Prolonged rapamycin treatment inhibits mTORC2 assembly and Akt/PKB. Mol Cell 22:159-168.
31. Yaba A, Bianchi V, Borini A, Johnson J. 2008. A putative mitotic checkpoint dependent on mTOR function controls cell proliferation and survival in ovarian granulosa cells. Reprod Sci 15:128-138.
32. Yu J, Yaba A, Kasiman C, Thomson T, Johnson J. 2011. mTOR controls ovarian follicle growth by regulating granulosa cell proliferation. PLoS ONE 6:e21415.
33. Zhang Z, Yu D, Yin D, Wang Z. 2011. Activation of PI3 K/mTOR signaling pathway contributes to induction of vascular endothelial growth factor by hCG in bovine developing luteal cells. Anim Reprod Sci 125:42-48.